Target intelligence / Profile preview

M-type potassium channel (M-channel)

Target
M-channel
Molecular classification
Ion channel, Voltage-gated potassium channel, Kv7 family, KCNQ family
01

Overview

M-type potassium channels are low-threshold, non-inactivating voltage-gated ion channels that play a fundamental role in regulating neuronal excitability throughout the central and peripheral nervous systems [1, 5]. They are primarily composed of heterotetramers of KCNQ2 and KCNQ3 subunits (also known as Kv7.2 and Kv7.3), although KCNQ4 and KCNQ5 can also contribute to the M-current [3, 10]. These channels are unique for being open at subthreshold membrane potentials, where they provide a stabilizing outward potassium current that acts as a "brake" on repetitive action potential firing and prevents hyperexcitability [8, 12]. The activity of M-channels is tightly regulated by various signaling molecules, most notably phosphatidylinositol 4,5-bisphosphate (PIP2) and muscarinic acetylcholine receptors, the latter of which inhibit the channel to increase neuronal responsiveness [4, 12]. Dysfunction or mutations in the genes encoding these subunits are directly linked to several forms of epilepsy, including benign familial neonatal convulsions (BFNC) [3, 9]. Consequently, M-type channels are significant therapeutic targets; pharmacological activators like retigabine have been developed to treat seizures and are being investigated for conditions such as chronic pain and tinnitus [6, 7, 10].

Other names
M-currentKv7 channelKCNQ channelNeuronal M-channelKCNQ2/3 channelKv7.2/7.3 channel
02

Mechanism of action

Positive allosteric modulation of KCNQ2-5 subunits to increase channel open probability and hyperpolarize the membrane potential; or inhibition via pore blockade or muscarinic receptor-mediated depletion of PIP2.

03

Biological functions

Regulation of neuronal excitabilitySpike frequency adaptationMaintenance of resting membrane potentialSignal transduction
04

Disease associations

EpilepsyNeuropathic painTinnitusStrokeCognitive impairment
05

Safety considerations

Blue skin discolorationRetinal pigmentary changesUrinary retentionDizzinessSomnolence
06

Interacting drugs

Retigabine

6 more in the full profile.

07

Biomarkers

KCNQ2 mutationKCNQ3 mutationM-current density

Beyond the preview

Go deeper on M-type potassium channel (M-channel).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on M-type potassium channel (M-channel).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call